Nitric oxide as a bactericidal agent: Is the cure worse than the disease?

Respiratory Care

Volumn 50, Issue 11, 2005, Pages 1428-1429

  Hurford, William E ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; BACTERICIDE; IRON; IRON SULFUR PROTEIN; NITRIC ACID; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE; THIOL;

ASPHYXIA; BACTERICIDAL ACTIVITY; BLEEDING; BREATHING; CELL HYPERPLASIA; DNA DAMAGE; DRUG FATALITY; EDITORIAL; ENZYME INACTIVATION; HEALTH CARE MANAGEMENT; HUMAN; LIPID PEROXIDATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG INFECTION; LUNG INJURY; LUNG PARENCHYMA; MEDICAL LITERATURE; MEDICAL RESEARCH; METHEMOGLOBINEMIA; MORTALITY; MUTATION; NITROSYLATION; OCCUPATIONAL SAFETY; SIDE EFFECT; ARTIFICIAL VENTILATION; CROSS INFECTION; INHALATIONAL DRUG ADMINISTRATION; MICROBIOLOGY; NOTE; PNEUMONIA;

ADMINISTRATION, INHALATION; CROSS INFECTION; HUMANS; NITRIC OXIDE; PNEUMONIA; RESPIRATION, ARTIFICIAL;

EID: 33644842513     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. McMullin B, Chittock D, Roscoe D, Garcha H, Wang L, Miller C. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the ICU. Respir Care 2005;50(11):1451-1456.
2. Bergeron Y, Ouellet N, Simard M, Olivier M, Bergeron MG. Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine. Antimicrob Agents Chemother 1999;43(9):2283-2290.
3. Fang FC. Perspectives series: Host/pathogen interactions: mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99(12):2818- 2825.
4. Hickman-Davis JM, O'Reilly P, Davis IC, Peti-Peterdi J, Davis G, Young KR, et al. Killing of Klebsiella pneumoniae by human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2002;282(5):L944-L956.
5. Freeman B. Free radical chemistry of nitric oxide: looking at the dark side. Chest 1994;105(3 Suppl):79S-84S.
6. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998;26(1):15-23.
7. Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967;39(5):388-392.
8. Greenbaum R, Bay J, Hargreaves MD, Kain ML, Kelman GR, Nunn JF, et al. Effects of higher oxides of nitrogen on the anesthetized dog. Br J Anaesth 1967;39(5):393-404.
9. Lehnert BE, Archuleta DC, Ellis T, Session WS, Lehnert NM, Gurley LR, Stavert DM. Lung injury following exposure of rats to relatively high mass concentrations of nitrogen dioxide. Toxicology 1994;89(3):239-277.
10. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89(7):3030-3034.
11. Centers for Disease Control. Recommendations for occupational safety and health standard. MMWR Morb Mortal Wkly Rep 1988;37:Suppl S-7-21.
12. 2 air space absorption in isolated rat lungs. J Appl Physiol 1992;73(5):1939-1945.
13. Shiel FO. Morbid anatomical changes in the lungs of dogs after inhalation of higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967;39(5):413-424.
14. Williams RA, Rhoades RA, Adams WS. The response of lung tissue and surfactant to nitrogen dioxide exposure. Arch Int Med 1971;128(1):101-108.
15. 2. Arch Environ Health 1972;24(3):180-188.
16. Stephens RJ, Freeman G, Evans MJ. Early response of lungs to low levels of nitrogen dioxide. Light and electron microscopy. Arch Environ Health 1972;24(3):160-179.
17. 2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis 1992;146(3):654-659.
18. Bylin G, Hedenstierna G, Lindvall T, Sundin B. Ambient nitrogen dioxide concentrations increase bronchial responsiveness in subjects with mild asthma. Eur Respir J 1988;1(7):606-612.
19. Frampton MW, Morrow PE, Cox C, Gibb FR, Speers DM, Utell MJ. Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans. Am Rev Respir Dis 1991;143(3):522-527.
20. Morrow PE, Utell MJ, Bauer MA, Smeglin AM, Frampton MW, Cox C, et al. Pulmonary performance of elderly normal subjects with chronic obstructive pulmonary disease exposed to 0.3 ppm nitrogen dioxide. Am Rev Respir Dis 1992;145(2 Pt 1):291-300.
21. Iwamoto J, Krasney JA, Morin FC 3rd. Methemoglobin production by nitric oxide in fresh sheep blood. Respir Physiol 1994;96(2-3):273-283.
22. Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999;340(1):23-30.
23. Keefer LK. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu Rev Pharmacol Toxicol 2003;43:585-607.